What are the precautions and dosage considerations when combining pregabalin and ketorolac (Non-Steroidal Anti-Inflammatory Drug, NSAID)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Combining Pregabalin and Ketorolac: Safety and Dosing Considerations

Pregabalin and ketorolac can be safely combined for multimodal pain management, but ketorolac use must be strictly limited to 5 days maximum, with careful attention to contraindications and monitoring requirements. 1

Evidence for Combined Use

The combination of pregabalin and ketorolac has demonstrated clinical efficacy in perioperative settings:

  • A prospective, double-blind randomized trial showed that an enhanced recovery pathway using preoperative pregabalin followed by perioperative ketorolac reduced morphine requirements by 40% and decreased hospital length of stay by 10% in live donor nephrectomy patients. 2
  • This multimodal approach leverages pregabalin's nerve desensitization effects with ketorolac's anti-inflammatory properties to achieve opioid-sparing analgesia. 2

Critical Ketorolac Limitations

The total duration of ketorolac therapy—whether IV, IM, or oral—must never exceed 5 days due to dose-dependent adverse reactions. 1, 3

Dosing Parameters:

  • Adults (17-64 years): 15-30 mg IV/IM every 6 hours, maximum 120 mg/day 3
  • Elderly (≥60 years): Reduce to 15 mg IV/IM every 6 hours due to increased risk of renal failure 3
  • Oral ketorolac should only be used as continuation therapy after IV/IM initiation 1

Absolute Contraindications for Ketorolac

Do not use ketorolac in patients with: 4, 3

  • Active or history of peptic ulcer disease
  • Aspirin/NSAID-induced asthma
  • Cerebrovascular bleeding or hemorrhage
  • Pregnancy
  • Thrombocytopenia or concurrent anticoagulant use
  • Severe renal impairment (compromised fluid status, interstitial nephritis)
  • Age >60 years with significant alcohol use or hepatic dysfunction

Pregabalin Dosing Considerations

Pregabalin demonstrates predictable linear pharmacokinetics with >90% bioavailability regardless of dose: 5, 6

For Neuropathic Pain:

  • Starting dose: 150 mg/day divided into 2-3 doses 7
  • Maximum dose: 300-600 mg/day depending on indication 7
  • Steady state achieved within 24-48 hours 5
  • No hepatic metabolism or cytochrome P450 interactions 5

Key Advantages:

  • Pregabalin can be administered with or without food 7
  • Dose adjustment required only in renal insufficiency (creatinine clearance <60 mL/min) 7, 8
  • When combined with ketorolac, pregabalin should be limited to a single preoperative dose to minimize sedation, dizziness, and peripheral edema 9

Monitoring Requirements When Using Ketorolac

Baseline assessment required: 3, 4

  • Blood pressure
  • BUN and creatinine
  • Liver function tests
  • Complete blood count
  • Fecal occult blood

Discontinue ketorolac immediately if: 10, 4

  • BUN or creatinine doubles
  • Hypertension develops or worsens
  • Liver function tests increase >3 times upper limit of normal
  • Signs of gastrointestinal bleeding occur

Common Pitfalls to Avoid

Never combine ketorolac with other NSAIDs (including ibuprofen, naproxen): The National Comprehensive Cancer Network explicitly warns against concurrent NSAID use due to additive gastrointestinal bleeding, renal toxicity, and cardiovascular risks without additional analgesic benefit. 10

  • If a patient has recently taken ibuprofen, wait 6-8 hours (approximately 3-4 half-lives) before administering ketorolac 10
  • Consider acetaminophen or opioid analgesics as bridging therapy during this waiting period 10

Gabapentinoid dosing in combination therapy: When pregabalin is used with ketorolac for perioperative pain, limit pregabalin to a single lowest effective preoperative dose rather than continuing postoperatively to avoid synergistic sedation with other analgesics. 9

Adverse Effects Profile

Pregabalin: 9

  • Blurred vision
  • Cognitive effects and sedation
  • Dizziness
  • Weight gain
  • Peripheral edema

Ketorolac: 3, 4

  • Edema
  • Drowsiness and dizziness
  • Gastrointestinal upset and increased diaphoresis
  • Highest risk of GI toxicity among NSAIDs with prolonged use 4

Clinical Algorithm for Combined Use

  1. Screen for ketorolac contraindications (peptic ulcer disease, renal impairment, age >60, bleeding disorders, cardiovascular disease) 4, 3

  2. Obtain baseline laboratory values (BP, BUN, creatinine, LFTs, CBC, fecal occult blood) 3

  3. Administer pregabalin preoperatively (single dose 75-150 mg, 1-2 hours before surgery) 9, 2

  4. Initiate ketorolac at end of surgery (15-30 mg IV, then every 6 hours) 3, 2

  5. Transition to oral NSAIDs (such as ibuprofen 600 mg every 6 hours) after 24-48 hours of ketorolac 3

  6. Discontinue ketorolac by day 5 regardless of pain control status 1, 3

  7. Monitor for complications throughout treatment course 4, 3

References

Research

Prospective, double-blind, randomized clinical trial comparing an ERAS pathway with ketorolac and pregabalin versus standard of care plus placebo during live donor nephrectomy for kidney transplant.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019

Guideline

Ketorolac Dosage and Usage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Contraindications and Precautions for Ketorolac Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pregabalin: new drug. Very similar to gabapentin.

Prescrire international, 2005

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Safe Use of Toradol After Ibuprofen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.